AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22574741 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 ml apple juice
Number of subjects: 12
Study 22574741 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 ml apple juice
Number of subjects: 12
Study 22574741 — intervention group
Group type: COMPARATOR
Intervention: 50 mg atenolol with 300 ml water
Number of subjects: 12
Study 21282869 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS with exercise
Number of subjects: 36
Study 21282869 — intervention group
Group type: COMPARATOR
Intervention: Placebo and exercise
Number of subjects: 36
Study 21282869 — intervention group
Group type: COMPARATOR
Intervention: Exercise only
Number of subjects: 36
Study 18794187 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐based cognitive‐behavioral therapy (NET)
Number of subjects: 73
Study 18794187 — intervention group
Group type: COMPARATOR
Intervention: Wait-list (WL)
Number of subjects: 73
Study 16536195 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Scotchbond Multi‐Purpose
Number of subjects: 96
Study 16536195 — intervention group
Group type: EXPERIMENTAL
Intervention: iBond
Number of subjects: 96
Study 16536195 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-Bond
Number of subjects: 96
Study 16536195 — intervention group
Group type: COMPARATOR
Intervention: All adhesive systems
Number of subjects: 96
Study 14580052 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 44
Study 14580052 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 44
Study 10827384 — intervention group
Group type: EXPERIMENTAL
Intervention: New York State multivariate risk score
Number of subjects: 3387
Study 10827384 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk lesion characteristics (calcium, thrombus, type C lesion)
Number of subjects: 3387
Study 9313245 — intervention group
Group type: EXPERIMENTAL
Intervention: Somnium (lorazepam 1 mg plus diphenhydramine 25 mg)
Number of subjects: 44
Study 9313245 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam (1 mg)
Number of subjects: 44
Study 8365305 — intervention group
Group type: EXPERIMENTAL
Intervention: ATIII (90 to 120 IU/kg in loading dose, then 90 to 120 IU/kg/d during 4 days)
Number of subjects: 35
Study 8365305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 8365305 — intervention group
Group type: EXPERIMENTAL
Intervention: ATIII
Number of subjects: 35
Study 3501753 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy (EST)
Number of subjects: 300
Study 3501753 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 29780153 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (IFX) treatment
Number of subjects: 301
Study 29780153 — intervention group
Group type: COMPARATOR
Intervention: Food-specific IgGs against egg, milk, wheat, corn, rice, tomato, codfish, and soybean
Number of subjects: 301
Study 29780153 — intervention group
Group type: COMPARATOR
Intervention: Total serum IgG and IgE levels
Number of subjects: 301
Study 29780153 — intervention group
Group type: COMPARATOR
Intervention: Corn- and tomato-specific IgGs
Number of subjects: 301
Study 29780153 — intervention group
Group type: COMPARATOR
Intervention: Egg-, milk-, and wheat-specific IgGs
Number of subjects: 301
Study 27429039 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasojejunal early enteral nutrition (NJEEN)
Number of subjects: 204
Study 27429039 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 204
Study 27429039 — intervention group
Group type: EXPERIMENTAL
Intervention: NJEEN
Number of subjects: 204
Study 27429039 — intervention group
Group type: COMPARATOR
Intervention: TPN
Number of subjects: 204
Study 24669774 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionation
Number of subjects: 124
Study 24669774 — intervention group
Group type: COMPARATOR
Intervention: Accelerated fractionation
Number of subjects: 124
Study 24669774 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 124
Study 24669774 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal interincisal distance
Number of subjects: 124
Study 24669774 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose to the ipsilateral masseter
Number of subjects: 124
Study 21734980 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium oxalate‐based desensitizing agent (BisBlock) with Adper Single Bond 2 adhesive
Number of subjects: 40
Study 21734980 — intervention group
Group type: COMPARATOR
Intervention: Adper Single Bond 2 adhesive without desensitizing agent
Number of subjects: 40
Study 21734980 — intervention group
Group type: EXPERIMENTAL
Intervention: One‐Step adhesive with potassium oxalate‐based desensitizing agent (BisBlock)
Number of subjects: 40
Study 21734980 — intervention group
Group type: COMPARATOR
Intervention: One‐Step adhesive without desensitizing agent
Number of subjects: 40
Study 20092585 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg
Number of subjects: 641
Study 20092585 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 641
Study 18432386 — intervention group
Group type: EXPERIMENTAL
Intervention: Micropolitan areas (medium and large towns)
Number of subjects: 62
Study 18432386 — intervention group
Group type: EXPERIMENTAL
Intervention: Metropolitan areas
Number of subjects: 62
Study 18432386 — intervention group
Group type: COMPARATOR
Intervention: Noncore areas (rural areas without towns and with small towns)
Number of subjects: 62
Study 18432386 — intervention group
Group type: EXPERIMENTAL
Intervention: Metropolitan and micropolitan areas
Number of subjects: 62
Study 22011421 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-to-smoker (DTS) outreach offering free tobacco treatment including up to 8 weeks of nicotine patches (NRT)
Number of subjects: 590
Study 22011421 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-to-smoker (DTS) outreach offering free tobacco treatment
Number of subjects: 590
Study 22011421 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 590
Study 16120137 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Behçet's disease (n = 26)
Number of subjects: 49
Study 16120137 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactive Behçet's disease (n = 23)
Number of subjects: 49
Study 16120137 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Behçet's disease patients (n = 49)
Number of subjects: 49
Study 11975712 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramlintide 30 microg t.i.d. for 5 days
Number of subjects: 12
Study 11975712 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramlintide 60 microg t.i.d. for 5 days
Number of subjects: 12
Study 11975712 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 microg pramlintide)
Number of subjects: 12
Study 9438756 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenectomy
Number of subjects: 55
Study 9438756 — intervention group
Group type: COMPARATOR
Intervention: No splenectomy
Number of subjects: 55
Study 7866397 — intervention group
Group type: EXPERIMENTAL
Intervention: Indigenized group counselling programme
Number of subjects: 100
Study 2681076 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% hydrocortisone plus 10% urea
Number of subjects: 0
Study 2681076 — intervention group
Group type: COMPARATOR
Intervention: hydrocortisone 17-valerate
Number of subjects: 0
Study 789436 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide (0.025% solution, two sprays in each nostril twice a day for 4 weeks)
Number of subjects: 51
Study 789436 — intervention group
Group type: COMPARATOR
Intervention: Vehicle alone (control group)
Number of subjects: 51
Study 789436 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide
Number of subjects: 51
Study 789436 — intervention group
Group type: COMPARATOR
Intervention: Flunisolide and Vehicle
Number of subjects: 51
Study 11564390 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat 25 mg
Number of subjects: 0
Study 11564390 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat 50 mg
Number of subjects: 0
Study 11564390 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat 25 mg and 50 mg
Number of subjects: 0
Study 11564390 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat
Number of subjects: 0
Study 11564390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30946283 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic pelvic organ prolapse suspension operation
Number of subjects: 368
Study 30811620 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave treatment at maximum energy level (5.8 GHz/axilla)
Number of subjects: 26
Study 30811620 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave treatment
Number of subjects: 26
Study 29937431 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotagliflozin 200 mg
Number of subjects: 782
Study 29937431 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotagliflozin 400 mg
Number of subjects: 782
Study 29937431 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotagliflozin
Number of subjects: 782
Study 29937431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 782
Study 26479510 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB) and low-pressure pneumoperitoneum (8 mmHg)
Number of subjects: 99
Study 26479510 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (single bolus of rocuronium 0.3 mg kg with spontaneous recovery) and standard-pressure pneumoperitoneum (12 mmHg)
Number of subjects: 99
Study 24679838 — intervention group
Group type: EXPERIMENTAL
Intervention: Dog technique (n = 30)
Number of subjects: 60
Study 24679838 — intervention group
Group type: EXPERIMENTAL
Intervention: Toggle-Recoil technique (n = 30)
Number of subjects: 60
Study 22339943 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief tobacco intervention during dental check-ups (up to four interventions)
Number of subjects: 2586
Study 22339943 — intervention group
Group type: COMPARATOR
Intervention: Control group (born on even days)
Number of subjects: 2586
Study 20456674 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdonation adapted motivational interview (AMI)
Number of subjects: 215
Study 20456674 — intervention group
Group type: COMPARATOR
Intervention: No-interview control group
Number of subjects: 215
Study 17505728 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromopride (5 mg/ml, 2 ml intravenous dose)
Number of subjects: 352
Study 17505728 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride, 2 ml intravenous dose)
Number of subjects: 352
Study 15741614 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (50 units)
Number of subjects: 40
Study 15741614 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (placebo)
Number of subjects: 40
Study 12570110 — intervention group
Group type: EXPERIMENTAL
Intervention: Home hospitalisation (HH)
Number of subjects: 222
Study 12570110 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 222
Study 10337859 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesterolone 100 mg orally daily (MES)
Number of subjects: 55
Study 10337859 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate 160 mg orally daily (TU)
Number of subjects: 55
Study 10337859 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate 250 mg intramuscularly every 21 days (TE)
Number of subjects: 55
Study 10337859 — intervention group
Group type: EXPERIMENTAL
Intervention: Single subcutaneous implantation of crystalline testosterone 1,200 mg (TPEL)
Number of subjects: 55
Study 8620719 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine polacrilex (NP) 2 mg
Number of subjects: 3923
Study 8620719 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine polacrilex (NP)
Number of subjects: 3923
Study 8620719 — intervention group
Group type: COMPARATOR
Intervention: Intensive instruction and monitoring of NP use
Number of subjects: 3923
Study 2015332 — intervention group
Group type: EXPERIMENTAL
Intervention: m-CPP (0.5 mg/kg)
Number of subjects: 6
Study 2015332 — intervention group
Group type: EXPERIMENTAL
Intervention: m-CPP
Number of subjects: 6
Study 2015332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 7202826 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen (3 single oral doses)
Number of subjects: 6
Study 7202826 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen (same dose)
Number of subjects: 6
Study 7202826 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen (increasing doses)
Number of subjects: 6
Study 31860533 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-tempo music (tempo ranging between 137 and 160 b·min)
Number of subjects: 10
Study 31860533 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 10
Study 31350765 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week empowerment-based self-care program
Number of subjects: 236
Study 31350765 — intervention group
Group type: COMPARATOR
Intervention: Didactic education program
Number of subjects: 236
Study 30303950 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided cutting-needle pleural biopsy
Number of subjects: 196
Study 30303950 — intervention group
Group type: COMPARATOR
Intervention: Thoracoscopic pleural biopsy
Number of subjects: 196
Study 27265269 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed components
Number of subjects: 0
Study 25322572 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-sealing drainage (VSD)
Number of subjects: 60
Study 25322572 — intervention group
Group type: COMPARATOR
Intervention: Traditional pressure dressing and drainage (control group)
Number of subjects: 60
Study 22040521 — intervention group
Group type: COMPARATOR
Intervention: Ketoconazole (400 mg once daily)
Number of subjects: 0
Study 22040521 — intervention group
Group type: COMPARATOR
Intervention: Valproic acid (VPA, sodium valproate, 1000 mg once daily)
Number of subjects: 0
Study 19410093 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% EDTA
Number of subjects: 42
Study 19410093 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% citric acid
Number of subjects: 42
Study 19410093 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% sodium citrate
Number of subjects: 42
Study 19410093 — intervention group
Group type: EXPERIMENTAL
Intervention: apple vinegar
Number of subjects: 42
Study 19410093 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% acetic acid
Number of subjects: 42
Study 19410093 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% malic acid
Number of subjects: 42
Study 19410093 — intervention group
Group type: EXPERIMENTAL
Intervention: sodium hypochlorite
Number of subjects: 42
Study 17449576 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium (7.28 g) and plant sterols (2 g)
Number of subjects: 33
Study 15915460 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg)
Number of subjects: 54
Study 15915460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 12225726 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP measurement using Shionogi and Biosite assays
Number of subjects: 2042
Study 12225726 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP measurement for detection of reduced ejection fraction
Number of subjects: 2042
Study 9798807 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole treatment
Number of subjects: 33
Study 9798807 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 33
Study 7900627 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory 24-hour Holter monitor recordings
Number of subjects: 20
Study 7900627 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral analysis of heart rate variability (HRV)
Number of subjects: 20
Study 2719896 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg buccal morphine
Number of subjects: 40
Study 2719896 — intervention group
Group type: COMPARATOR
Intervention: 10 mg intramuscular morphine
Number of subjects: 40
Study 835542 — intervention group
Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid 250 mg
Number of subjects: 13
Study 835542 — intervention group
Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid 500 mg
Number of subjects: 13
Study 835542 — intervention group
Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid 750 mg
Number of subjects: 13
Study 835542 — intervention group
Group type: COMPARATOR
Intervention: Control (0 mg)
Number of subjects: 13
Study 31136549 — intervention group
Group type: EXPERIMENTAL
Intervention: Red Spinach Extract (RSE) 1 g daily for 7 days
Number of subjects: 17
Study 31136549 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 17
Study 30022620 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care guide package and three face-to-face educational sessions
Number of subjects: 152
Study 30022620 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical services (control)
Number of subjects: 152
Study 27861932 — intervention group
Group type: EXPERIMENTAL
Intervention: Swallow therapy interventions
Number of subjects: 168
Study 25885432 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention (booklet format) with follow-up phone calls for 12 weeks
Number of subjects: 121
Study 25885432 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 121
Study 24195839 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture and placebo medicine
Number of subjects: 184
Study 24195839 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture and Naproxen Sustained Release Tablets
Number of subjects: 184
Study 21334853 — intervention group
Group type: EXPERIMENTAL
Intervention: Perphenazine
Number of subjects: 0
Study 21334853 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study 21334853 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 0
Study 21334853 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0
Study 21334853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 0
Study 21334853 — intervention group
Group type: EXPERIMENTAL
Intervention: Total serum cholesterol
Number of subjects: 0
Study 21334853 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglycerides
Number of subjects: 0
Study 19808338 — intervention group
Group type: EXPERIMENTAL
Intervention: PAC
Number of subjects: 133
Study 19808338 — intervention group
Group type: COMPARATOR
Intervention: CLIN
Number of subjects: 133
Study 17567343 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooled saline bag (study group)
Number of subjects: 100
Study 17567343 — intervention group
Group type: COMPARATOR
Intervention: Saline bag at room temperature (control group)
Number of subjects: 100
Study 15451330 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefenamic acid, 500 mg, twice a day for 5 days
Number of subjects: 48
Study 15451330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 15451330 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 48
Study 11446878 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg b.i.d.) with amoxicillin (500 mg t.i.d.)
Number of subjects: 199
Study 11446878 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole (10 mg b.i.d.) with amoxicillin (500 mg t.i.d.)
Number of subjects: 199
Study 10209375 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tenoxicam 20 mg
Number of subjects: 0
Study 10209375 — intervention group
Group type: COMPARATOR
Intervention: Epidural fentanyl 100 micrograms
Number of subjects: 0
Study 7600216 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA therapy (8‐methoxypsoralen 0.6 mg/kg administered orally 2 hours before irradiation)
Number of subjects: 18
Study 7600216 — intervention group
Group type: COMPARATOR
Intervention: Control sites (not treated with PUVA)
Number of subjects: 18
Study 2192446 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral incision (new approach)
Number of subjects: 37
Study 2192446 — intervention group
Group type: COMPARATOR
Intervention: Midline incision (prior standard approach)
Number of subjects: 37
Study 365428 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (17 mg) substituted for methyldopa
Number of subjects: 21
Study 365428 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (14 mg) added to methyldopa and hydrochlorothiazide
Number of subjects: 21
Study 31473913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal nerve block
Number of subjects: 43
Study 31473913 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 43
Study 31473913 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 43
Study 31094262 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry short-term heat acclimation (STHA)
Number of subjects: 11
Study 31094262 — intervention group
Group type: EXPERIMENTAL
Intervention: Humid short-term heat acclimation (STHA)
Number of subjects: 11
Study 28029362 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 2887
Study 28029362 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI) with drug-eluting stents
Number of subjects: 2887
Study 26157049 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg daily
Number of subjects: 147
Study 26157049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 24274190 — intervention group
Group type: EXPERIMENTAL
Intervention: Acticoat™
Number of subjects: 84
Study 24274190 — intervention group
Group type: EXPERIMENTAL
Intervention: Acticoat™ combined with Mepitel™
Number of subjects: 84
Study 24274190 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepilex Ag™
Number of subjects: 84
Study 24274190 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 84
Study 21266910 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART-BF
Number of subjects: 1719
Study 21266910 — intervention group
Group type: COMPARATOR
Intervention: ZDV-BF
Number of subjects: 1719
Study 21266910 — intervention group
Group type: COMPARATOR
Intervention: ZDV-FF
Number of subjects: 1719
Study 19201180 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish-flour spread rich in n-3 long-chain polyunsaturated fatty acids
Number of subjects: 183